PODXL and gastric adenocarcinoma: In osteosarcoma cell lines, PODXL has been shown to promote chemoresistance to cisplatin [32], which is particularly interesting since platinum compounds (cisplatin and oxaliplatin) are important cytotoxic drugs in the treatment of esophageal and gastric adenocarcinoma.